Medication info
Aliem Tablets 25/5 mg (Empagliflozin, Linagliptin)

Aliem Tablets 25/5 mg (Empagliflozin, Linagliptin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin Amorphous›25mg / 1 tabletLinagliptin Micronized›5mg / 1 tablet
Manufacturer / importer
Alico Pharmaceutical Co., Ltd.
Appearance
Flat on both sides, with sharp edges, pale pink triangular film-coated tablet
Packaging
30 tablets per bottle
Approval status
Active

MFDS item code 202502160 · Approved 2025.08.20 · Insurance code 656005850

Summary

Main use
Improvement of blood glucose control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended starting dose of this drug is empagliflozin 10 mg/linagliptin 5 mg once daily. If additional glycemic control is needed and empagliflozin 10 mg/linagliptin 5 mg is tolerated, the dose of this drug may be increased to 25/5 mg once daily. Patients switching to this drug from combination therapy with empagliflozin and linagliptin should receive their previous doses. This drug may be taken with or without food. Swallow the tablet whole. If a dose of this drug is missed, take it as soon as remembered. However, if the next dose is due within 12 hours, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. Patients with renal impairment This drug is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dosage adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or greater. Patients with hepatic impairment No dosage adjustment is necessary in patients with mild or moderate hepatic impairment. Since this drug has not been studied in patients with severe hepatic impairment, its use is not recommended. Elderly patients No dosage adjustment is necessary based on age. In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Alico Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to assist patients with type 2 diabetes in controlling blood glucose levels while adhering to dietary and exercise regimens. Empagliflozin and Linagliptin work together to effectively improve blood glucose levels. This combination treatment is suitable for patients who have difficulty managing their blood sugar and is expected to provide better blood glucose control. Therefore, it is used as an important adjunct therapy in diabetes management.

How to take

Adult dose

The recommended starting dose of this drug is empagliflozin 10 mg/linagliptin 5 mg once daily. If additional glycemic control is needed and empagliflozin 10 mg/linagliptin 5 mg is tolerated, the dose of this drug may be increased to 25/5 mg once daily. Patients switching to this drug from combination therapy with empagliflozin and linagliptin should receive their previous doses. This drug may be taken with or without food. Swallow the tablet whole. If a dose of this drug is missed, take it as soon as remembered. However, if the next dose is due within 12 hours, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. Patients with renal impairment This drug is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dosage adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or greater. Patients with hepatic impairment No dosage adjustment is necessary in patients with mild or moderate hepatic impairment. Since this drug has not been studied in patients with severe hepatic impairment, its use is not recommended. Elderly patients No dosage adjustment is necessary based on age. In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Precautions

This medication contains two components, Empagliflozin and Linagliptin, for diabetes treatment. First, this medication should not be used in individuals who are allergic to Empagliflozin, Linagliptin, or any of the other components of the drug. Additionally, this medication should not be administered to patients with type 1 diabetes, diabetic ketoacidosis, or those undergoing kidney dialysis. Patients with impaired kidney function should use this medication cautiously and regularly monitor their kidney function. Some heart failure patients have limited experience with this medication, so it should be administered carefully. There may be side effects such as acute pancreatitis or bullous pemphigoid, so if abdominal pain or skin blisters occur, you should consult your physician immediately and stop taking the medication. During treatment with this medication, urinary tract infections, genital infections, hypoglycemia, and symptoms of dehydration may occur, and any unusual symptoms should be reported to medical staff promptly. Particularly, if taken with insulin or sulfonylureas, there is an increased risk of hypoglycemia, so caution is necessary. Elderly patients over 75 years of age are at higher risk for dehydration or hypotension, so extra caution is needed when taking this medication. Pregnant or breastfeeding women are advised to avoid using this medication and should consult healthcare professionals as necessary. The safety and efficacy of this medication have not been established for children and adolescents under 18 years of age, and it is not recommended for this group. In case of overdose, immediate medical attention should be sought, and this medication should be kept out of the reach of children. Lastly, while taking this medication, be cautious about the risk of hypoglycemia when driving or operating machinery.

Side effects

  • Urinary tract infection
  • Vulvovaginal candidiasis
  • Vulvitis
  • Balanitis
  • Hypersensitivity reaction
  • Angioedema
  • Urticaria
  • Hypoglycemia
  • Thirst
  • Ketoacidosis
Show 178 more
  • Cough
  • Constipation
  • Pancreatitis
  • Oral ulcer
  • Pruritus
  • Rash
  • Vesicular pemphigoid
  • Rhabdomyolysis
  • Decreased fluid volume
  • Increased urination
  • Urinary retention
  • Interstitial nephritis
  • Increased amylase
  • Increased lipase
  • Increased hematocrit
  • Increased serum lipids
  • Elevated serum creatinine
  • Upper abdominal pain
  • Enterocolitis
  • Bowel obstruction
  • Gastroenteritis
  • Shingles
  • Cystitis
  • Acute pyelonephritis
  • Bronchitis
  • Vestibular neuritis
  • Sepsis
  • Pneumonia
  • Decreased appetite
  • Dehydration
  • Hyperglycemia
  • Cerebral infarction
  • Stuttering
  • Alzheimer's type dementia
  • Chest pain
  • Fever
  • Facial edema
  • Fatigue
  • Death
  • Chronic obstructive pulmonary disease
  • Asthma
  • Diabetic foot disease
  • Skin lesions
  • Liver metastasis
  • Acute leukemia
  • Basal cell carcinoma
  • Non-small cell lung cancer
  • Malignant pericardial effusion
  • Stomach cancer
  • Rectal cancer
  • Pancreatic cancer
  • Meniscal injury
  • Pneumoconiosis
  • Congestive heart failure
  • Angina pectoris
  • Acute myocardial infarction
  • Unstable angina
  • Cardiac arrest
  • Diabetic retinopathy
  • Acute kidney injury
  • End-stage kidney disease
  • Acute cholangitis
  • Acute cholecystitis
  • Cholangitis
  • Dizziness
  • Renal transplant failure
  • Constipation
  • Upper abdominal pain
  • Burning mouth syndrome
  • Colitis
  • Abdominal discomfort
  • Dysphagia
  • Gastric ulcer
  • Gum bleeding
  • Hemorrhoids
  • Lower abdominal pain
  • Diarrhea
  • Vomiting
  • Gastritis
  • Nail psoriasis
  • Rhinitis
  • Soft tissue infection
  • Pharyngitis
  • Tsutsugamushi disease
  • Periodontitis
  • Tonsillitis
  • Laryngitis
  • Viral upper respiratory infection
  • Tonsillitis
  • Nosebleed
  • Oropharyngeal pain
  • Speech disorder
  • Allergic rhinitis
  • Exertional dyspnea
  • Wet cough
  • Nasal discharge
  • Skin laceration
  • Rib fracture
  • Osteoarthritis
  • Limb pain
  • Insomnia
  • Depression
  • Anxiety
  • Itching
  • Benign prostatic hyperplasia
  • Vulvar pruritus
  • Genital pruritus
  • Hypoglycemia
  • Decreased appetite
  • Obesity
  • Drowsiness
  • Diabetes
  • Hyperlipidemia
  • Hyponatremia
  • Dermal cyst
  • Seborrheic dermatitis
  • Atopic dermatitis
  • Nummular eczema
  • Heat rash
  • Sebaceous gland hyperplasia
  • Lumbar spinal canal stenosis
  • Myalgia
  • Musculoskeletal chest pain
  • Cervical stenosis
  • Fibromyalgia
  • Side pain
  • Fracture pain
  • Muscle weakness
  • Osteoporosis
  • Rotator cuff syndrome
  • Astigmatism
  • Allergic conjunctivitis
  • Blurred vision
  • Corneal erosion
  • Macular fibrosis
  • Ocular discomfort
  • Eye congestion
  • Swelling of the eyelids
  • Vitreous floaters
  • Vitreous hemorrhage
  • Nosebleed
  • Exertional dyspnea
  • Moist cough
  • Sputum retention
  • Positional dizziness
  • Sensory loss
  • Perceptual disturbance
  • Amnesia
  • Carotid artery stenosis
  • Facial paralysis
  • Memory disturbance
  • Neuralgia
  • Parkinsonism
  • Polyneuropathy
  • Sensory impairment
  • Drowsiness
  • Weight gain
  • Electrocardiogram abnormalities
  • Hemoglobin decrease
  • Hemoglobin increase
  • Helicobacter test positive
  • Urine red blood cells positive
  • Vascular stent stenosis
  • Vascular stent thrombosis
  • Vascular disorders
  • Hypotension
  • Flushing
  • Hepatic steatosis
  • Cholelithiasis
  • Hearing loss
  • Earache
  • Positional vertigo
  • Erectile dysfunction
  • Goiter
  • Anemia
  • Lymphadenopathy
  • Hypothyroidism
  • Thyroid nodule

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. Additionally, the medication should be kept at a cool room temperature, preferably between 1 to 30 degrees Celsius. Proper storage will help to maintain the medication's effectiveness for a long time.

Appearance and packaging

Appearance

Flat on both sides, with sharp edges, pale pink triangular film-coated tablet

Package unit

30 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.